Vital drugs are either not authorized or are deemed too expensive, as cases rise.

Rates of tuberculosis are on the rise in Europe, but countries are ill-equipped and lack access to the latest drugs targeting the worst strains.

Some patients are spending a year and a half in hospital isolation receiving old medicines instead of just six months of treatment at home, because countries do not have access to the most up-to-date therapies to cure people of the infectious disease.

In some EU countries, the latest medicines are either not authorized or are deemed too expensive to use. To effectively treat patients, the NGO Doctors Without Borders (Médecins Sans Frontières, MSF) has stepped in to help in Poland and Slovakia.

Earlier this year, the European Centre for Disease Prevention and Control (EDC) and the World Health Organization (WHO) warned that Europe was stalling in its quest to suppress tuberculosis and could miss its 2030 targets to end the disease. The agencies caution that if Europe doesn’t get a grip on the rising rates of infection with the recommended cocktail of drugs, the gains made over the last decade could be lost.

  • romp_2_door@lemmy.world
    link
    fedilink
    English
    arrow-up
    1
    ·
    4 days ago

    restricting access to a cure is does not equal hurting.

    By that logic, not inventing a cure, when you could otherwise do so, is also hurting. So companies developing chronic medicines instead of cures would be actively engaging in hurt

    which does not make sense

    • Killing_Spark@feddit.de
      link
      fedilink
      English
      arrow-up
      1
      ·
      4 days ago

      No that’s not the same. In one case there is only the theoretical possibility of help whereas in the other case there is a realizable possibility for help. This is a big difference.